Compare Johnson & Johnson (JNJ) vs NRG Energy Inc (NRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs NRG Energy Inc — how do they compare? Johnson & Johnson trades at $248.49 (market cap $598.96B), while NRG Energy Inc trades at $132.3 (market cap $27.55B). The key difference: Johnson & Johnson is far larger — about 21.7× NRG Energy Inc's market cap, and Johnson & Johnson pays the higher dividend (2.15%). Which is the better fit depends on your goals.
| JNJ | NRG | |
|---|---|---|
Market Cap | $598.96B | $27.55B |
Volume | 6,156,228 | — |
Sector | Health | Utilities |
52-Week High | $267.24 | $184.03 |
52-Week Low | $164.36 | $120.65 |
Enterprise Value | $631.90B | $51.38B |
Dividend Yield | 2.15% | 1.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $249.58, down 1.37% today, amid a generally bullish technical outlook with strong moving average signals. The company reported robust Q2 2026 earnings, beating EPS estimates and raising full-year guidance, with revenue growth to $94.19B in 2025 and a net income margin of 21.48%. Recent news highlights strong institutional interest and positive analyst sentiment, though the stock faces pressure from MedTech segment misses despite overall strength.
The outlook for JNJ remains positive, supported by solid fundamentals, a consistent dividend history, and upward revised earnings guidance. Key risks include competitive pressures in pharmaceuticals, regulatory hurdles, and execution challenges in the MedTech division. With a consensus price target of $279.33, representing ~12% upside, the stock offers a compelling opportunity for long-term investors, balanced by sector-specific volatility and macroeconomic factors.
NRG Energy trades at $131.02, up 1.48% with a bearish technical signal despite recent earnings beats. The stock shows mixed fundamentals with strong revenue growth to $30.71B but thin net margins of 0.74%. Analyst consensus remains bullish with a $196.33 price target, representing 50% upside potential from current levels. Recent news highlights expanding generation capacity and data center deals as growth catalysts.
The outlook balances strong analyst support against elevated valuation multiples and technical weakness. Key opportunities include power demand growth and strategic positioning, while risks involve margin pressure and debt levels exceeding 56% of assets. The upcoming Q2 2026 earnings report on August 4 will be critical for confirming growth trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →
